Medicover AB (publ)

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, FSNUY has a market cap of 95.7B. Regarding current trading prices, MCVEY is priced at $16.55, while FSNUY trades at $10.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas FSNUY's P/E ratio is 13.61. In terms of profitability, MCVEY's ROE is +0.16%, compared to FSNUY's ROE of +0.08%. Regarding short-term risk, MCVEY is more volatile compared to FSNUY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check FSNUY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, FSNUF has a market cap of 30.6B. Regarding current trading prices, MCVEY is priced at $16.55, while FSNUF trades at $54.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas FSNUF's P/E ratio is 17.42. In terms of profitability, MCVEY's ROE is +0.16%, compared to FSNUF's ROE of +0.08%. Regarding short-term risk, MCVEY is more volatile compared to FSNUF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check FSNUF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, JDHIF has a market cap of 18.8B. Regarding current trading prices, MCVEY is priced at $16.55, while JDHIF trades at $5.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas JDHIF's P/E ratio is 23.40. In terms of profitability, MCVEY's ROE is +0.16%, compared to JDHIF's ROE of +0.09%. Regarding short-term risk, MCVEY is more volatile compared to JDHIF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check JDHIF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, JDHIY has a market cap of 17.2B. Regarding current trading prices, MCVEY is priced at $16.55, while JDHIY trades at $5.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas JDHIY's P/E ratio is 21.40. In terms of profitability, MCVEY's ROE is +0.16%, compared to JDHIY's ROE of +0.09%. Regarding short-term risk, MCVEY is less volatile compared to JDHIY. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check JDHIY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, IHHHF has a market cap of 15.1B. Regarding current trading prices, MCVEY is priced at $16.55, while IHHHF trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas IHHHF's P/E ratio is 28.50. In terms of profitability, MCVEY's ROE is +0.16%, compared to IHHHF's ROE of +0.07%. Regarding short-term risk, MCVEY is more volatile compared to IHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check IHHHF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, FMCQF has a market cap of 11.3B. Regarding current trading prices, MCVEY is priced at $16.55, while FMCQF trades at $42.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas FMCQF's P/E ratio is 11.02. In terms of profitability, MCVEY's ROE is +0.16%, compared to FMCQF's ROE of +0.07%. Regarding short-term risk, MCVEY is more volatile compared to FMCQF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check FMCQF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BDUUF has a market cap of 10.2B. Regarding current trading prices, MCVEY is priced at $16.55, while BDUUF trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BDUUF's P/E ratio is 21.33. In terms of profitability, MCVEY's ROE is +0.16%, compared to BDUUF's ROE of +0.15%. Regarding short-term risk, MCVEY is more volatile compared to BDUUF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check BDUUF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BDUUY has a market cap of 9.3B. Regarding current trading prices, MCVEY is priced at $16.55, while BDUUY trades at $23.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BDUUY's P/E ratio is 19.18. In terms of profitability, MCVEY's ROE is +0.16%, compared to BDUUY's ROE of +0.15%. Regarding short-term risk, MCVEY is more volatile compared to BDUUY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check BDUUY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BDULF has a market cap of 8.9B. Regarding current trading prices, MCVEY is priced at $16.55, while BDULF trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BDULF's P/E ratio is 18.67. In terms of profitability, MCVEY's ROE is +0.16%, compared to BDULF's ROE of +0.15%. Regarding short-term risk, MCVEY is more volatile compared to BDULF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check BDULF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RMYHY has a market cap of 6.5B. Regarding current trading prices, MCVEY is priced at $16.55, while RMYHY trades at $7.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RMYHY's P/E ratio is 30.96. In terms of profitability, MCVEY's ROE is +0.16%, compared to RMYHY's ROE of +0.06%. Regarding short-term risk, MCVEY is more volatile compared to RMYHY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RMYHY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RMSYF has a market cap of 5.7B. Regarding current trading prices, MCVEY is priced at $16.55, while RMSYF trades at $24.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RMSYF's P/E ratio is 351.57. In terms of profitability, MCVEY's ROE is +0.16%, compared to RMSYF's ROE of +0.06%. Regarding short-term risk, MCVEY is more volatile compared to RMSYF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RMSYF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BUHPF has a market cap of 4.3B. Regarding current trading prices, MCVEY is priced at $16.55, while BUHPF trades at $5.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BUHPF's P/E ratio is 20.96. In terms of profitability, MCVEY's ROE is +0.16%, compared to BUHPF's ROE of +0.25%. Regarding short-term risk, MCVEY is more volatile compared to BUHPF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check BUHPF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, MCVEF has a market cap of 4.1B. Regarding current trading prices, MCVEY is priced at $16.55, while MCVEF trades at $27.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas MCVEF's P/E ratio is 52.40. In terms of profitability, MCVEY's ROE is +0.16%, compared to MCVEF's ROE of +0.15%. Regarding short-term risk, MCVEY is less volatile compared to MCVEF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check MCVEF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, MCVEY is priced at $16.55, while ANHGY trades at $5.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, MCVEY's ROE is +0.16%, compared to ANHGY's ROE of N/A. Regarding short-term risk, MCVEY is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check ANHGY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BUGDF has a market cap of 3.8B. Regarding current trading prices, MCVEY is priced at $16.55, while BUGDF trades at $4.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BUGDF's P/E ratio is 16.96. In terms of profitability, MCVEY's ROE is +0.16%, compared to BUGDF's ROE of +0.25%. Regarding short-term risk, MCVEY is more volatile compared to BUGDF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check BUGDF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, MCVEY is priced at $16.55, while ORPEF trades at $14.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, MCVEY's ROE is +0.16%, compared to ORPEF's ROE of -0.20%. Regarding short-term risk, MCVEY is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check ORPEF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, EXETF has a market cap of 2.2B. Regarding current trading prices, MCVEY is priced at $16.55, while EXETF trades at $23.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas EXETF's P/E ratio is 23.83. In terms of profitability, MCVEY's ROE is +0.16%, compared to EXETF's ROE of +0.45%. Regarding short-term risk, MCVEY is more volatile compared to EXETF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check EXETF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, LWSCF has a market cap of 1.5B. Regarding current trading prices, MCVEY is priced at $16.55, while LWSCF trades at $15.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas LWSCF's P/E ratio is 43.94. In terms of profitability, MCVEY's ROE is +0.16%, compared to LWSCF's ROE of +0.06%. Regarding short-term risk, MCVEY is more volatile compared to LWSCF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check LWSCF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RAFLF has a market cap of 1.5B. Regarding current trading prices, MCVEY is priced at $16.55, while RAFLF trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RAFLF's P/E ratio is 26.67. In terms of profitability, MCVEY's ROE is +0.16%, compared to RAFLF's ROE of +0.05%. Regarding short-term risk, MCVEY is more volatile compared to RAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RAFLF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RHCGF has a market cap of 1.4B. Regarding current trading prices, MCVEY is priced at $16.55, while RHCGF trades at $1.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RHCGF's P/E ratio is -5.04. In terms of profitability, MCVEY's ROE is +0.16%, compared to RHCGF's ROE of -0.04%. Regarding short-term risk, MCVEY is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check RHCGF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RYHTY has a market cap of 1.2B. Regarding current trading prices, MCVEY is priced at $16.55, while RYHTY trades at $6.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RYHTY's P/E ratio is -4.59. In terms of profitability, MCVEY's ROE is +0.16%, compared to RYHTY's ROE of -0.04%. Regarding short-term risk, MCVEY is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RYHTY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, LTGHF has a market cap of 1.2B. Regarding current trading prices, MCVEY is priced at $16.55, while LTGHF trades at $0.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas LTGHF's P/E ratio is 13.58. In terms of profitability, MCVEY's ROE is +0.16%, compared to LTGHF's ROE of +7.19%. Regarding short-term risk, MCVEY is more volatile compared to LTGHF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check LTGHF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, TTALF has a market cap of 1.1B. Regarding current trading prices, MCVEY is priced at $16.55, while TTALF trades at $8.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas TTALF's P/E ratio is 12.61. In terms of profitability, MCVEY's ROE is +0.16%, compared to TTALF's ROE of +0.14%. Regarding short-term risk, MCVEY is more volatile compared to TTALF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check TTALF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RKAGY has a market cap of 1.1B. Regarding current trading prices, MCVEY is priced at $16.55, while RKAGY trades at $8.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RKAGY's P/E ratio is 24.73. In terms of profitability, MCVEY's ROE is +0.16%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, MCVEY is more volatile compared to RKAGY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RKAGY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, MCVEY is priced at $16.55, while RHKJF trades at $15.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, MCVEY's ROE is +0.16%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, MCVEY is more volatile compared to RHKJF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RHKJF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, LTGHY has a market cap of 930.7M. Regarding current trading prices, MCVEY is priced at $16.55, while LTGHY trades at $2.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas LTGHY's P/E ratio is -10.00. In terms of profitability, MCVEY's ROE is +0.16%, compared to LTGHY's ROE of +0.38%. Regarding short-term risk, MCVEY is more volatile compared to LTGHY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check LTGHY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NWKHY has a market cap of 871.6M. Regarding current trading prices, MCVEY is priced at $16.55, while NWKHY trades at $7.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NWKHY's P/E ratio is 10.39. In terms of profitability, MCVEY's ROE is +0.16%, compared to NWKHY's ROE of +0.17%. Regarding short-term risk, MCVEY is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check NWKHY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, WHTCF has a market cap of 810.3M. Regarding current trading prices, MCVEY is priced at $16.55, while WHTCF trades at $3.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas WHTCF's P/E ratio is 39.65. In terms of profitability, MCVEY's ROE is +0.16%, compared to WHTCF's ROE of +0.03%. Regarding short-term risk, MCVEY is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check WHTCF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, JXFGF has a market cap of 755.4M. Regarding current trading prices, MCVEY is priced at $16.55, while JXFGF trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas JXFGF's P/E ratio is -5.80. In terms of profitability, MCVEY's ROE is +0.16%, compared to JXFGF's ROE of -0.11%. Regarding short-term risk, MCVEY is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check JXFGF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, MCVEY is priced at $16.55, while KDGTF trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, MCVEY's ROE is +0.16%, compared to KDGTF's ROE of N/A. Regarding short-term risk, MCVEY is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check KDGTF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, WFHG has a market cap of 476.9M. Regarding current trading prices, MCVEY is priced at $16.55, while WFHG trades at $7.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas WFHG's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to WFHG's ROE of +0.00%. Regarding short-term risk, MCVEY is more volatile compared to WFHG. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check WFHG's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, MCVEY is priced at $16.55, while ORRRY trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, MCVEY's ROE is +0.16%, compared to ORRRY's ROE of +7.04%. Regarding short-term risk, MCVEY is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check ORRRY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, MCVEY is priced at $16.55, while BTMDW trades at $1.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, MCVEY's ROE is +0.16%, compared to BTMDW's ROE of -0.23%. Regarding short-term risk, MCVEY is more volatile compared to BTMDW. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check BTMDW's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, MFCSF has a market cap of 222.2M. Regarding current trading prices, MCVEY is priced at $16.55, while MFCSF trades at $12.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas MFCSF's P/E ratio is 14.39. In terms of profitability, MCVEY's ROE is +0.16%, compared to MFCSF's ROE of +0.31%. Regarding short-term risk, MCVEY is more volatile compared to MFCSF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check MFCSF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, MKLNF has a market cap of 214.8M. Regarding current trading prices, MCVEY is priced at $16.55, while MKLNF trades at $11.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, MCVEY's ROE is +0.16%, compared to MKLNF's ROE of +0.19%. Regarding short-term risk, MCVEY is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check MKLNF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, HWAIF has a market cap of 193.9M. Regarding current trading prices, MCVEY is priced at $16.55, while HWAIF trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas HWAIF's P/E ratio is -9.37. In terms of profitability, MCVEY's ROE is +0.16%, compared to HWAIF's ROE of -0.32%. Regarding short-term risk, MCVEY is more volatile compared to HWAIF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check HWAIF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, CHHHF has a market cap of 152.9M. Regarding current trading prices, MCVEY is priced at $16.55, while CHHHF trades at $2.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas CHHHF's P/E ratio is 7.77. In terms of profitability, MCVEY's ROE is +0.16%, compared to CHHHF's ROE of +0.27%. Regarding short-term risk, MCVEY is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check CHHHF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, COLRF has a market cap of 123M. Regarding current trading prices, MCVEY is priced at $16.55, while COLRF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas COLRF's P/E ratio is -8.00. In terms of profitability, MCVEY's ROE is +0.16%, compared to COLRF's ROE of +0.00%. Regarding short-term risk, MCVEY is less volatile compared to COLRF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check COLRF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, VTIAF has a market cap of 111.1M. Regarding current trading prices, MCVEY is priced at $16.55, while VTIAF trades at $6.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas VTIAF's P/E ratio is -9.11. In terms of profitability, MCVEY's ROE is +0.16%, compared to VTIAF's ROE of -0.53%. Regarding short-term risk, MCVEY is more volatile compared to VTIAF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check VTIAF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, TOKIF has a market cap of 101.4M. Regarding current trading prices, MCVEY is priced at $16.55, while TOKIF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas TOKIF's P/E ratio is -0.57. In terms of profitability, MCVEY's ROE is +0.16%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, MCVEY is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check TOKIF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, MCVEY is priced at $16.55, while MCIOF trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, MCVEY's ROE is +0.16%, compared to MCIOF's ROE of N/A. Regarding short-term risk, MCVEY is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check MCIOF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NAFS has a market cap of 49.1M. Regarding current trading prices, MCVEY is priced at $16.55, while NAFS trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NAFS's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to NAFS's ROE of +0.31%. Regarding short-term risk, MCVEY is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check NAFS's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, MCVEY is priced at $16.55, while ASSF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas ASSF's P/E ratio is -33.33. In terms of profitability, MCVEY's ROE is +0.16%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, MCVEY is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check ASSF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NVLPF has a market cap of 24.7M. Regarding current trading prices, MCVEY is priced at $16.55, while NVLPF trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NVLPF's P/E ratio is 28.30. In terms of profitability, MCVEY's ROE is +0.16%, compared to NVLPF's ROE of +0.01%. Regarding short-term risk, MCVEY is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check NVLPF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, MCVEY is priced at $16.55, while USNU trades at $1.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas USNU's P/E ratio is -9.41. In terms of profitability, MCVEY's ROE is +0.16%, compared to USNU's ROE of -1.91%. Regarding short-term risk, MCVEY is more volatile compared to USNU. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check USNU's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, MCVEY is priced at $16.55, while HQDA trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas HQDA's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to HQDA's ROE of -0.06%. Regarding short-term risk, MCVEY is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check HQDA's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RHEPB has a market cap of 11.9M. Regarding current trading prices, MCVEY is priced at $16.55, while RHEPB trades at $6.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RHEPB's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to RHEPB's ROE of +2.11%. Regarding short-term risk, MCVEY is more volatile compared to RHEPB. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RHEPB's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, MCVEY is priced at $16.55, while FPCG trades at $1,025.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas FPCG's P/E ratio is 0.09. In terms of profitability, MCVEY's ROE is +0.16%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, MCVEY is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check FPCG's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, GBCS has a market cap of 9.1M. Regarding current trading prices, MCVEY is priced at $16.55, while GBCS trades at $2.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas GBCS's P/E ratio is 1.67. In terms of profitability, MCVEY's ROE is +0.16%, compared to GBCS's ROE of -1.37%. Regarding short-term risk, MCVEY is less volatile compared to GBCS. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check GBCS's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NUMIF has a market cap of 7.4M. Regarding current trading prices, MCVEY is priced at $16.55, while NUMIF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NUMIF's P/E ratio is -0.77. In terms of profitability, MCVEY's ROE is +0.16%, compared to NUMIF's ROE of +11.51%. Regarding short-term risk, MCVEY is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check NUMIF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BICX has a market cap of 7.3M. Regarding current trading prices, MCVEY is priced at $16.55, while BICX trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BICX's P/E ratio is -2.19. In terms of profitability, MCVEY's ROE is +0.16%, compared to BICX's ROE of +0.28%. Regarding short-term risk, MCVEY is more volatile compared to BICX. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check BICX's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, HLYK has a market cap of 6.7M. Regarding current trading prices, MCVEY is priced at $16.55, while HLYK trades at $2.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas HLYK's P/E ratio is -1.69. In terms of profitability, MCVEY's ROE is +0.16%, compared to HLYK's ROE of +0.67%. Regarding short-term risk, MCVEY is more volatile compared to HLYK. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check HLYK's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, MAHN has a market cap of 6.1M. Regarding current trading prices, MCVEY is priced at $16.55, while MAHN trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas MAHN's P/E ratio is 250.00. In terms of profitability, MCVEY's ROE is +0.16%, compared to MAHN's ROE of N/A. Regarding short-term risk, MCVEY is less volatile compared to MAHN. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check MAHN's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RVLWF has a market cap of 5.4M. Regarding current trading prices, MCVEY is priced at $16.55, while RVLWF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, MCVEY's ROE is +0.16%, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, MCVEY is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RVLWF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, JRSS has a market cap of 5.1M. Regarding current trading prices, MCVEY is priced at $16.55, while JRSS trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas JRSS's P/E ratio is -0.17. In terms of profitability, MCVEY's ROE is +0.16%, compared to JRSS's ROE of -0.07%. Regarding short-term risk, MCVEY is less volatile compared to JRSS. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check JRSS's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, XCRT has a market cap of 4.2M. Regarding current trading prices, MCVEY is priced at $16.55, while XCRT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas XCRT's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to XCRT's ROE of +0.70%. Regarding short-term risk, MCVEY is more volatile compared to XCRT. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check XCRT's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, VLXC has a market cap of 3.2M. Regarding current trading prices, MCVEY is priced at $16.55, while VLXC trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas VLXC's P/E ratio is -3.25. In terms of profitability, MCVEY's ROE is +0.16%, compared to VLXC's ROE of +0.74%. Regarding short-term risk, MCVEY is more volatile compared to VLXC. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check VLXC's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, RHEP has a market cap of 2.6M. Regarding current trading prices, MCVEY is priced at $16.55, while RHEP trades at $1.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas RHEP's P/E ratio is 0.66. In terms of profitability, MCVEY's ROE is +0.16%, compared to RHEP's ROE of +2.11%. Regarding short-term risk, MCVEY is more volatile compared to RHEP. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check RHEP's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, MCVEY is priced at $16.55, while EPWCF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas EPWCF's P/E ratio is -0.00. In terms of profitability, MCVEY's ROE is +0.16%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, MCVEY is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check EPWCF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, EVGRF has a market cap of 2.2M. Regarding current trading prices, MCVEY is priced at $16.55, while EVGRF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas EVGRF's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to EVGRF's ROE of +0.22%. Regarding short-term risk, MCVEY is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check EVGRF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NRPR has a market cap of 2.1M. Regarding current trading prices, MCVEY is priced at $16.55, while NRPR trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NRPR's P/E ratio is -0.03. In terms of profitability, MCVEY's ROE is +0.16%, compared to NRPR's ROE of N/A. Regarding short-term risk, MCVEY is more volatile compared to NRPR. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check NRPR's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, KJFI has a market cap of 2.1M. Regarding current trading prices, MCVEY is priced at $16.55, while KJFI trades at $0.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas KJFI's P/E ratio is -0.06. In terms of profitability, MCVEY's ROE is +0.16%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, MCVEY is more volatile compared to KJFI. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check KJFI's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, MCVEY is priced at $16.55, while SMAS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas SMAS's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to SMAS's ROE of N/A. Regarding short-term risk, MCVEY is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check SMAS's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, MCVEY is priced at $16.55, while MDGP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas MDGP's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, MCVEY is more volatile compared to MDGP. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check MDGP's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, MCVEY is priced at $16.55, while NOVC trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NOVC's P/E ratio is -0.20. In terms of profitability, MCVEY's ROE is +0.16%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, MCVEY is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check NOVC's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, DPAT has a market cap of 1.1M. Regarding current trading prices, MCVEY is priced at $16.55, while DPAT trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas DPAT's P/E ratio is -2.25. In terms of profitability, MCVEY's ROE is +0.16%, compared to DPAT's ROE of +0.59%. Regarding short-term risk, MCVEY is more volatile compared to DPAT. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check DPAT's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, MCVEY is priced at $16.55, while PHMB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas PHMB's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to PHMB's ROE of N/A. Regarding short-term risk, MCVEY is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check PHMB's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, MCVEY is priced at $16.55, while GNOW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas GNOW's P/E ratio is -0.01. In terms of profitability, MCVEY's ROE is +0.16%, compared to GNOW's ROE of -12.49%. Regarding short-term risk, MCVEY is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check GNOW's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, JNHMF has a market cap of 779.5K. Regarding current trading prices, MCVEY is priced at $16.55, while JNHMF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas JNHMF's P/E ratio is -0.01. In terms of profitability, MCVEY's ROE is +0.16%, compared to JNHMF's ROE of -101.83%. Regarding short-term risk, MCVEY is more volatile compared to JNHMF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check JNHMF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, GRST has a market cap of 772.6K. Regarding current trading prices, MCVEY is priced at $16.55, while GRST trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas GRST's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to GRST's ROE of +0.17%. Regarding short-term risk, MCVEY is more volatile compared to GRST. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check GRST's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, MCVEY is priced at $16.55, while MSITF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas MSITF's P/E ratio is -0.10. In terms of profitability, MCVEY's ROE is +0.16%, compared to MSITF's ROE of N/A. Regarding short-term risk, MCVEY is less volatile compared to MSITF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check MSITF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, MCVEY is priced at $16.55, while ARPC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas ARPC's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to ARPC's ROE of +3.10%. Regarding short-term risk, MCVEY is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check ARPC's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NXGT has a market cap of 288.5K. Regarding current trading prices, MCVEY is priced at $16.55, while NXGT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NXGT's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to NXGT's ROE of +0.03%. Regarding short-term risk, MCVEY is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check NXGT's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BNYN has a market cap of 286K. Regarding current trading prices, MCVEY is priced at $16.55, while BNYN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BNYN's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, MCVEY is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check BNYN's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, SETO has a market cap of 137.2K. Regarding current trading prices, MCVEY is priced at $16.55, while SETO trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas SETO's P/E ratio is -1.10. In terms of profitability, MCVEY's ROE is +0.16%, compared to SETO's ROE of -0.15%. Regarding short-term risk, MCVEY is more volatile compared to SETO. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check SETO's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, FCHS has a market cap of 131.8K. Regarding current trading prices, MCVEY is priced at $16.55, while FCHS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas FCHS's P/E ratio is -0.02. In terms of profitability, MCVEY's ROE is +0.16%, compared to FCHS's ROE of +0.19%. Regarding short-term risk, MCVEY is more volatile compared to FCHS. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check FCHS's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, MCVEY is priced at $16.55, while TPIA trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas TPIA's P/E ratio is -0.15. In terms of profitability, MCVEY's ROE is +0.16%, compared to TPIA's ROE of +0.56%. Regarding short-term risk, MCVEY is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check TPIA's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, MCVEY is priced at $16.55, while AMBD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas AMBD's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, MCVEY is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check AMBD's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, MCVEY is priced at $16.55, while NMHLY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, MCVEY's ROE is +0.16%, compared to NMHLY's ROE of N/A. Regarding short-term risk, MCVEY is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check NMHLY's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, MSGP has a market cap of 31.1K. Regarding current trading prices, MCVEY is priced at $16.55, while MSGP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas MSGP's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, MCVEY is less volatile compared to MSGP. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check MSGP's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, DRWN has a market cap of 24K. Regarding current trading prices, MCVEY is priced at $16.55, while DRWN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas DRWN's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, MCVEY is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check DRWN's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, PRMD has a market cap of 20.3K. Regarding current trading prices, MCVEY is priced at $16.55, while PRMD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas PRMD's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, MCVEY is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check PRMD's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, HSMD has a market cap of 18.4K. Regarding current trading prices, MCVEY is priced at $16.55, while HSMD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas HSMD's P/E ratio is -0.01. In terms of profitability, MCVEY's ROE is +0.16%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, MCVEY is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check HSMD's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, MCVEY is priced at $16.55, while SCAL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas SCAL's P/E ratio is 0.04. In terms of profitability, MCVEY's ROE is +0.16%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, MCVEY is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check SCAL's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, GENN has a market cap of 12.1K. Regarding current trading prices, MCVEY is priced at $16.55, while GENN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas GENN's P/E ratio is -0.01. In terms of profitability, MCVEY's ROE is +0.16%, compared to GENN's ROE of +0.07%. Regarding short-term risk, MCVEY is less volatile compared to GENN. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check GENN's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, MCVEY is priced at $16.55, while CHCR trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas CHCR's P/E ratio is -0.00. In terms of profitability, MCVEY's ROE is +0.16%, compared to CHCR's ROE of N/A. Regarding short-term risk, MCVEY is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check CHCR's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, MCVEY is priced at $16.55, while ACGI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas ACGI's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, MCVEY is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check ACGI's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, CLRD has a market cap of 10.5K. Regarding current trading prices, MCVEY is priced at $16.55, while CLRD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas CLRD's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, MCVEY is less volatile compared to CLRD. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check CLRD's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, CEVE has a market cap of 8.6K. Regarding current trading prices, MCVEY is priced at $16.55, while CEVE trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas CEVE's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, MCVEY is less volatile compared to CEVE. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check CEVE's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, PAOG has a market cap of 7.4K. Regarding current trading prices, MCVEY is priced at $16.55, while PAOG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas PAOG's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to PAOG's ROE of +0.03%. Regarding short-term risk, MCVEY is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check PAOG's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, WEQL has a market cap of 7.2K. Regarding current trading prices, MCVEY is priced at $16.55, while WEQL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas WEQL's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, MCVEY is less volatile compared to WEQL. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check WEQL's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, SLHGF has a market cap of 4K. Regarding current trading prices, MCVEY is priced at $16.55, while SLHGF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas SLHGF's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to SLHGF's ROE of -0.42%. Regarding short-term risk, MCVEY is less volatile compared to SLHGF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check SLHGF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, MCVEY is priced at $16.55, while SLHPF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas SLHPF's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to SLHPF's ROE of -0.42%. Regarding short-term risk, MCVEY is less volatile compared to SLHPF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check SLHPF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, MCVEY is priced at $16.55, while ERUC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas ERUC's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to ERUC's ROE of N/A. Regarding short-term risk, MCVEY is more volatile compared to ERUC. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check ERUC's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, MCVEY is priced at $16.55, while BBAL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas BBAL's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, MCVEY is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check BBAL's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, MCVEY is priced at $16.55, while NMMCF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, MCVEY's ROE is +0.16%, compared to NMMCF's ROE of +0.21%. Regarding short-term risk, MCVEY is more volatile compared to NMMCF. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check NMMCF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, MCVEY is priced at $16.55, while PPRG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas PPRG's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, MCVEY is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check PPRG's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, KONEF has a market cap of 1.6K. Regarding current trading prices, MCVEY is priced at $16.55, while KONEF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas KONEF's P/E ratio is N/A. In terms of profitability, MCVEY's ROE is +0.16%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, MCVEY is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for MCVEY.Check KONEF's competition here

MCVEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCVEY stands at 2.5B. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, MCVEY is priced at $16.55, while OHAQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCVEY currently has a P/E ratio of 40.37, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, MCVEY's ROE is +0.16%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, MCVEY is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for MCVEY.Check OHAQ's competition here